The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase II study of abemaciclib and ramucirumab in metastatic esophageal/gastroesophageal junction carcinoma.
 
Ronan Joseph Kelly
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sanyo; Eisai; EMD Serono; Ipsen; Lilly; McKesson; Medscape; Merck; Novartis; Onc Live; Peerview; Philips Healthcare; Pieris Pharmaceuticals; Takeda
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
Expert Testimony - Merck
 
Vincent K. Lam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Seagen; Takeda; Takeda
Research Funding - BMS (Inst); GlaxoSmithKline (Inst); Merck (Inst); Seagen (Inst)
 
Scott Paulson
No Relationships to Disclose
 
Natalie Settele
No Relationships to Disclose
 
Oghenevovwero Sido
No Relationships to Disclose
 
Valsamo Anagnostou
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Moses S. Raj
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - BMS speakers bureau
Speakers' Bureau - BMS speakers bureau
 
Ali Hussainy Zaidi
No Relationships to Disclose